4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-004507
SVP, CHIEF FINANCIAL OFFICER gave up 15,752 shares (to pay taxes)
- SVP, CHIEF FINANCIAL OFFICER acquired 29,085 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-15 | Option exercise | +1,254 | 16,734 | D | ||
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-15 | Shares withheld for taxes | −741 | $58.29 | $43,193 | 15,993 | D |
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-16 | Option exercise | +17,409 | 33,402 | D | ||
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-16 | Shares withheld for taxes | −9,400 | $58.29 | $547,926 | 24,002 | D |
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-16 | Option exercise | +5,093 | 29,095 | D | ||
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-16 | Shares withheld for taxes | −2,742 | $58.29 | $159,831 | 26,353 | D |
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-16 | Option exercise | +5,329 | 31,682 | D | ||
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-16 | Shares withheld for taxes | −2,869 | $58.29 | $167,234 | 28,813 | D |
| Derivatives | |||||||
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-15 | Option exercise · Restricted Stock Units | −1,254 | 0 | D | ||
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-16 | Option exercise · Performance Stock Units | −17,409 | 0 | D | ||
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-16 | Option exercise · Restricted Stock Units | −5,093 | 5,093 | D | ||
| LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2025-02-16 | Option exercise · Restricted Stock Units | −5,329 | 10,658 | D | ||
Loading xslF345X05/form4-02182025_110210.xml…